EdgarLookup

Gitlab Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Gitlab Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
-5.9%
Profit Margin
Net income ÷ revenue
-3.2%
Return on Assets
Net income ÷ assets
0.69x
Debt-to-Equity
Total liabilities ÷ equity
+25.8%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $955.22M Mar 17, 2026
FY2026 Jan 31, 2025 $759.25M Mar 17, 2026
FY2026 Jan 31, 2024 $579.91M Mar 17, 2026
FY2025 Jan 31, 2023 $424.34M Mar 21, 2025
FY2024 Jan 31, 2022 $252.65M Mar 26, 2024
FY2023 Jan 31, 2021 $152.18M Mar 30, 2023
FY2022 Jan 31, 2020 $81.23M Apr 8, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 ($55.96M) Mar 17, 2026
FY2026 Jan 31, 2025 ($6.33M) Mar 17, 2026
FY2026 Jan 31, 2024 ($425.68M) Mar 17, 2026
FY2025 Jan 31, 2023 ($173.41M) Mar 21, 2025
FY2024 Jan 31, 2022 ($155.14M) Mar 26, 2024
FY2023 Jan 31, 2021 ($192.19M) Mar 30, 2023
FY2022 Jan 31, 2020 ($130.74M) Apr 8, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 ($70.48M) Mar 17, 2026
FY2026 Jan 31, 2025 ($142.72M) Mar 17, 2026
FY2026 Jan 31, 2024 ($187.44M) Mar 17, 2026
FY2025 Jan 31, 2023 ($211.41M) Mar 21, 2025
FY2024 Jan 31, 2022 ($128.96M) Mar 26, 2024
FY2023 Jan 31, 2021 ($213.88M) Mar 30, 2023
FY2022 Jan 31, 2020 ($128.37M) Apr 8, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $1.72B Mar 17, 2026
FY2026 Jan 31, 2025 $1.40B Mar 17, 2026
FY2025 Jan 31, 2024 $1.32B Mar 21, 2025
FY2024 Jan 31, 2023 $1.17B Mar 26, 2024
FY2023 Jan 31, 2022 $1.09B Mar 30, 2023
FY2022 Jan 31, 2021 $362.57M Apr 8, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $686.50M Mar 17, 2026
FY2026 Jan 31, 2025 $577.96M Mar 17, 2026
FY2025 Jan 31, 2024 $715.01M Mar 21, 2025
FY2024 Jan 31, 2023 $344.48M Mar 26, 2024
FY2023 Jan 31, 2022 $292.17M Mar 30, 2023
FY2022 Jan 31, 2021 $168.88M Apr 8, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $990.67M Mar 17, 2026
FY2026 Jan 31, 2025 $775.91M Mar 17, 2026
FY2025 Jan 31, 2024 $559.77M Mar 21, 2025
FY2024 Jan 31, 2023 $771.02M Mar 26, 2024
FY2023 Jan 31, 2022 $774.87M Mar 30, 2023
FY2022 Jan 31, 2021 ($231.22M) Apr 8, 2022

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 0 Mar 17, 2026
FY2026 Jan 31, 2025 0 Mar 17, 2026
FY2026 Jan 31, 2024 (2) Mar 17, 2026
FY2025 Jan 31, 2023 (1) Mar 21, 2025
FY2024 Jan 31, 2022 (1) Mar 26, 2024
FY2023 Jan 31, 2021 (3) Mar 30, 2023
FY2022 Jan 31, 2020 (2) Apr 8, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 0 Mar 17, 2026
FY2026 Jan 31, 2025 0 Mar 17, 2026
FY2026 Jan 31, 2024 (2) Mar 17, 2026
FY2025 Jan 31, 2023 (1) Mar 21, 2025
FY2024 Jan 31, 2022 (1) Mar 26, 2024
FY2023 Jan 31, 2021 (3) Mar 30, 2023
FY2022 Jan 31, 2020 (2) Apr 8, 2022

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2026 Jan 31, 2026 $229.58M Mar 17, 2026
FY2026 Jan 31, 2025 $227.65M Mar 17, 2026
FY2025 Jan 31, 2024 $288.00M Mar 21, 2025
FY2025 Jan 31, 2023 $295.40M Mar 21, 2025
FY2024 Jan 31, 2022 $884.67M Mar 26, 2024
FY2023 Jan 31, 2021 $282.85M Mar 30, 2023
FY2022 Jan 31, 2020 $343.33M Apr 8, 2022